The LRRK2 p.L1795F variant causes Parkinson's disease in the European population.
Saved in:
| Title: | The LRRK2 p.L1795F variant causes Parkinson's disease in the European population. |
|---|---|
| Authors: | Lange LM; Institute of Neurogenetics, University of Luebeck, Luebeck, Germany. la.lange@uni-luebeck.de.; Department of Neurology, University Hospital Schleswig-Holstein, Luebeck, Germany. la.lange@uni-luebeck.de.; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. la.lange@uni-luebeck.de., Levine K; DataTecnica, Washington, DC, USA.; Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Fox SH; Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada., Marras C; Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada., Ahmed N; Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada., Kuznetsov N; DataTecnica, Washington, DC, USA.; Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Vitale D; DataTecnica, Washington, DC, USA.; Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Iwaki H; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.; DataTecnica, Washington, DC, USA.; Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Lohmann K; Institute of Neurogenetics, University of Luebeck, Luebeck, Germany., Marsili L; University of Cincinnati, Cincinnati, OH, USA., Espay AJ; University of Cincinnati, Cincinnati, OH, USA., Bauer P; CENTOGENE GmbH, Rostock, Germany., Beetz C; CENTOGENE GmbH, Rostock, Germany., Martin J; Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Factor SA; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA., Higginbotham LA; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA., Chen H; Department of Epidemiology and Biostatistics, Michigan State University, Michigan, MI, USA., Leonard H; DataTecnica, Washington, DC, USA.; Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Nalls MA; DataTecnica, Washington, DC, USA.; Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Mencacci NE; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Morris HR; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.; UCL Movement Disorders Centre, University College London, London, UK., Singleton AB; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.; Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Klein C; Institute of Neurogenetics, University of Luebeck, Luebeck, Germany.; Department of Neurology, University Hospital Schleswig-Holstein, Luebeck, Germany., Blauwendraat C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.; Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Fang ZH; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. Zih-Hua.Fang@dzne.de. |
| Corporate Authors: | Global Parkinson’s Genetics Program (GP2) |
| Source: | NPJ Parkinson's disease [NPJ Parkinsons Dis] 2025 Mar 25; Vol. 11 (1), pp. 58. Date of Electronic Publication: 2025 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2373-8057 |
|---|---|
| DOI: | 10.1038/s41531-025-00896-2 |
